Patent · US Expired

Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences

US5783188A · kind A · utility

9Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateJul 21, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/543
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to a method and pharmaceutical formulations for the treatment of autoimmune arthritis and animal models therefore in mammals, including humans, by the oral, enteral or by-inhalation administration of whole collagen protein or biologically active peptide fragments of collagen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.